Skip to main content
. 2013 Nov 1;10(2):492–497. doi: 10.4161/hv.26888

Table 4. Avoided costs and cases for the first targeted group.

Total costs without vaccination Total costs with vaccination program Avoided costs N. of cases without vaccination program N. of cases with vaccination program Avoided pneumococcal CAP cases
€64 467 625 €35 461 965 €29 005 660 4083 509 3574